COMMUNIQUÉS West-GlobeNewswire

Cytospire Therapeutics announces oversubscribed £61 million ($83m) Series A financing to advance pipeline of first-in-class pan-gamma delta T cell engagers into clinical trials for the treatment of cancer
05/05/2026
Series A financing led by 4BIO Capital, with major new investors Servier Ventures, Sound Bioventures, British Business Bank and Criteria Bio Ventures, supported by existing investors Abingworth and LifeArc Ventures [...]
neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia
05/05/2026
Munich, Germany and Riyadh, Saudi Arabia - neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, is pleased to announce the Saudi Food & Drug Authority (SFDA [...]
Novonesis delivered strong start to the year with 7% organic sales growth in Q1
05/05/2026
COPENHAGEN, Denmark – May 5, 2026. In the first quarter of 2026, Novonesis delivered strong organic sales growth of 7% and an adjusted EBITDA margin of 37.8%. Ester Baiget, President & CEO: “The year started strong [...]
Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT)
05/05/2026
Press Release Organ transplantation: ALS achieved CE Certification for PERLA®, The new class of solution – PPS – and launches a randomized comparative clinical trial (RCT) ALS has received CE marking approval for PERLA [...]
Transplantation d’organes : ALS obtient le marquage CE pour PERLA®, une nouvelle classe de solution - PPS - et lance une étude clinique comparative
05/05/2026
COMMUNIQUÉ DE PRESSE Transplantation d’organes : ALS obtient le marquage CE pour PERLA®, une nouvelle classe de solution - PPS - et lance une étude clinique comparative Obtention du marquage CE pour PERLA®, Solution de [...]
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares
05/05/2026
Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares Cash runway remains into Q4 2027, supporting continued funding of clinical programs and pre- [...]
Interim report Q1 2026
05/05/2026
Strong start to the year with 7% organic sales growth and 37.8% adjusted EBITDA margin Ester Baiget, President & CEO: ” The year started strong with 7% organic sales growth against a high comparable. We delivered [...]
Santhera Publishes Agenda for its Annual General Meeting
05/05/2026
Ad hoc announcement pursuant to Art. 53 LR. Pratteln, Switzerland, May 5, 2026 – Santhera Pharmaceuticals (SIX: SANN) today published the invitation to its Annual General Meeting (AGM), which will be held on May 26, [...]
Axavive Under Investigation: Inspecting the Axon Renewal Anti-Aging Benefits of the Secret Golden Seed Astragaloside IV Skin Care Supplement
05/05/2026
Axavive Ingredients Bacopa Monnieri, Centella Asiatica, Cistanche Deserticola, and Collagen Support Pathways in the Axon Renewal Skin Support Supplement Framework Explained for 2026 Tallmadge, Ohio, May 04, 2026 (GLOBE [...]
GL Control Claims Evaluated: Investigating the Ingredients Benefits for Blood Sugar Trap Support
05/05/2026
GL Control Supplement Facts Reviewed: Cinnamon, Bitter Melon, Resveratrol, Licorice Root, Turmeric, and Coriander in the Blood Sugar Trap Liquid Tincture Formula for 2026 Tallmadge, OH, May 04, 2026 (GLOBE NEWSWIRE) -- [...]
Vital Wrist Monitor & Vital Wrist Ball Under Investigation: Evaluating the Brand Claims & Product Benefits
05/05/2026
How Vital Wrist Monitor's Blood Pressure Tracking and Vital Wrist Ball's Progressive Gyroscopic Resistance Work: At-Home Wrist Health Devices Explained for 2026 Miami, FL, May 04, 2026 (GLOBE NEWSWIRE) -- Results may [...]
Axavive Claims Evaluated: The Golden Seed Switch for Healthy Skin Support
05/05/2026
Axavive Ingredients, Axon Renewal Framework, Astragaloside IV, Centella Asiatica, and Skin Support Supplement Claims Explained for 2026 Tallmadge, OH, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Pennant Announces First Quarter 2026 Earnings Release and Call
05/05/2026
EAGLE, Idaho, May 04, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it [...]
Janell Rae Releases Debut Book Satori: Awakening to Your Truest Self Through Energy Intelligence
05/05/2026
After 25 years of transformative client work, Janell Rae brings her complete Energy Intelligence Method™ to readers for the first time — offering a direct path back to the most authentic version of themselves. Silver [...]
Elite Pro Force Male Enhancement Gummies Claims Evaluated: The Ultra Peak Horse Gelatin Trick for Men
04/05/2026
How Elite Pro Force Male Enhancement Gummies Ingredients, Blood Flow Claims, and Non-Prescription Male Vitality Support Work in 2026 Chicago, IL, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
04/05/2026
PARIS and CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘ Company ’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand [...]
NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU
04/05/2026
PARIS et CAMBRIDGE, Mass., 04 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO – NASDAQ : NBTX – la « Société »), société française de biotechnologie en phase de développement clinique avancé, pionnière des [...]
JellyFit Claims Evaluated: The Truth About Jelly Lean Fit Weight Loss Drops' 8 Ingredients Stacked with Gelatin Trick Recipe Hack Exposed
04/05/2026
JellyFit's 8-Ingredient Liquid Weight Loss Drops: Apple Cider Vinegar, Apple Pectin, Beet Root, and the Gelatin Trick Formula Explained for 2026 Largo, FL, May 04, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
04/05/2026
MELBOURNE, Australia and INDIANAPOLIS, May 05, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the publication of a new independent analysis of Phase 3 ZIRCON [...]

Pages